Citi Downgrades Apellis Pharmaceuticals (APLS) to Neutral

March 31, 2026 4:12 PM

Citi analyst Yigal Nochomovitz downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found